Identification of conserved and HLA-A*2402-restricted epitopes in Dengue virus serotype 2

Virus Research

Volumn 196, Issue , 2015, Pages 5-12

  Duan, Zhi Liang ^a,b   Liu, Hui Fang ^a   Huang, Xi ^c,d   Wang, Si Na ^a   Yang, Jin Lin ^a   Chen, Xin Yu ^b   Li, De Zhou ^e   Zhong, Xiao Zhi ^a   Chen, Bo Kun ^a   Wen, Jin Sheng ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL AND YUYING CHILDREN S HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d SUN YAT SEN UNIVERSITY   (China)

^e The Third Hospital of Ningbo   (China)

Author keywords

Dengue virus; Epitope; HLA A*2402

Indexed keywords

GAMMA INTERFERON; HLA A24 ANTIGEN; HLA A2402 ANTIGEN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; EPITOPE; HLA A ANTIGEN; PEPTIDE;

ALLELE; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS 2; FEMALE; MONOCYTE; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; SPLEEN CELL; ANIMAL; CELL LINE; CHEMISTRY; CLASSIFICATION; CYTOTOXIC T LYMPHOCYTE; DENGUE VIRUS; DISEASE MODEL; EPITOPE MAPPING; HUMAN; IMMUNIZATION; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; SEROTYPE; TRANSGENIC MOUSE;

DENGUE VIRUS; MUS MUSCULUS;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CYTOKINES; DENGUE; DENGUE VIRUS; DISEASE MODELS, ANIMAL; EPITOPE MAPPING; EPITOPES; EPITOPES, T-LYMPHOCYTE; FEMALE; HLA-A ANTIGENS; HUMANS; IMMUNIZATION; IMMUNOPHENOTYPING; MICE, TRANSGENIC; PEPTIDES; SEROGROUP; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84920735757     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2014.10.022     Document Type: Article

References (26)

1. + T cells have both protective and pathogenic roles in dengue virus infection. Immunol. Lett. 2004, 95:167-174.
2. Bozza F.A., Cruz O.G., Zagne S.M., Azeredo E.L., Nogueira R.M., Assis E.F., Bozza P.T., Kubelka C.F. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect. Dis. 2008, 8:86.
3. Callaway E. Dengue fever climbs the social ladder. Nature 2007, 448:734-735.
4. Chen L.C., Lei H.Y., Liu C.C., Shiesh S.C., Chen S.H., Liu H.S., Lin Y.S., Wang S.T., Shyu H.W., Yeh T.M. Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. Am. J. Trop. Med. Hyg. 2006, 74:142-147.
5. Diamond M.S., Harris E. Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism. Virology 2001, 289:297-311.
6. Diamond M.S., Roberts T.G., Edgil D., Lu B., Ernst J., Harris E. Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. J. Virol. 2000, 74:4957-4966.
7. Duangchinda T., Dejnirattisai W., Vasanawathana S., Limpitikul W., Tangthawornchaikul N., Malasit P., Mongkolsapaya J., Screaton G. Immunodominant T-cell responses to dengue virus NS3 are associated with DHF. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:16922-16927.
8. Green S., Vaughn D.W., Kalayanarooj S., Nimmannitya S., Suntayakorn S., Nisalak A., Lew R., Innis B.L., Kurane I., Rothman A.L., Ennis F.A. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J. Infect. Dis. 1999, 179:755-762.
9. Hober D., Poli L., Roblin B., Gestas P., Chungue E., Granic G., Imbert P., Pecarere J.L., Vergez-Pascal R., Wattre P., Maniez-Montreuil M. Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients. Am. J. Trop. Med. Hyg. 1993, 48:324-331.
10. Imrie A., Meeks J., Gurary A., Sukhbataar M., Kitsutani P., Effler P., Zhao Z. Differential functional avidity of dengue virus-specific T-cell clones for variant peptides representing heterologous and previously encountered serotypes. J. Virol. 2007, 81:10081-10091.
11. Kyle J.L., Beatty P.R., Harris E. Dengue virus infects macrophages and dendritic cells in a mouse model of infection. J. Infect. Dis. 2007, 195:1808-1817.
12. Lund O., Nascimento E.J., Maciel M., Nielsen M., Larsen M.V., Lundegaard C., Harndahl M., Lamberth K., Buus S., Salmon J., August T.J., Marques E.T. Human leukocyte antigen (HLA) class I restricted epitope discovery in yellow fewer and dengue viruses: importance of HLA binding strength. PLoS ONE 2011, 6:e26494.
13. Mathew A., Rothman A.L. Understanding the contribution of cellular immunity to dengue disease pathogenesis. Immunol. Rev. 2008, 225:300-313.
14. McArthur M.A., Sztein M.B., Edelman R. Dengue vaccines: recent developments, ongoing challenges and current candidates. Expert. Rev. Vaccin. 2013, 12:933-953.
15. Nascimento E.J., Mailliard R.B., Khan A.M., Sidney J., Sette A., Guzman N., Paulaitis M., de Melo A.B., Cordeiro M.T., Gil L.V., Lemonnier F., Rinaldo C., August J.T., Marques E.T Identification of conserved and HLA promiscuous DENV3 T-cell epitopes. PLoS Negl. Trop. Dis. 2013, 7:e2497.
16. Petersen J., Wurzbacher S.J., Williamson N.A., Ramarathinam S.H., Reid H.H., Nair A.K., Zhao A.Y., Nastovska R., Rudge G., Rossjohn J., Purcell A.W. Phosphorylated self-peptides alter human leukocyte antigen class I-restricted antigen presentation and generate tumor-specific epitopes. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:2776-2781.
17. Prestwood T.R., May M.M., Plummer E.M., Morar M.M., Yauch L.E., Shresta S. Trafficking and replication patterns reveal splenic macrophages as major targets of dengue virus in mice. J. Virol. 2012, 86:12138-12147.
18. Priyadarshini D., Gadia R.R., Tripathy A., Gurukumar K.R., Bhagat A., Patwardhan S., Mokashi N., Vaidya D., Shah P.S., Cecilia D. Clinical findings and pro-inflammatory cytokines in dengue patients in Western India: a facility-based study. PLoS ONE 2010, 5:e8709.
19. + T lymphocytes in dengue virus infection. J. Virol. 2012, 87:2693-2706.
20. Simmons C.P., Dong T., Chau N.V., Dung N.T., Chau T.N., Thao le T.T., Dung N.T., Hien T.T., Rowland-Jones S., Farrar J. Early T cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections. J. Virol. 2005, 79:5665-5675.
21. Steidel M., Fragnoud R., Guillotte M., Roesch C., Michel S., Meunier T., Paranhos-Baccalà G., Gervasi G., Bedin F. Nonstructural protein NS1 immunodominant epitope detected specifically in dengue virus infected material by a SELDI-TOF/MS based assay. J. Med. Virol. 2012, 84:490-499.
22. Testa J.S., Shetty V., Sinnathamby G., Nickens Z., Hafner J., Kamal S., Zhang X., Jett M., Philip R. Conserved MHC class I-presented dengue virus epitopes identified by immunoproteomics analysis are targets for cross-serotype reactive T-cell response. J. Infect. Dis. 2012, 205:647-655.
23. Weiskopf D., Yauch L.E., Angelo M.A., John D.V., Greenbaum J.A., Sidney J., Kolla R.V., De Silva A.D., de Silva A.M., Grey H., Peters B., Shresta S., Sette A. Insights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine design. J. Immunol. 2011, 187:4268-4279.
24. + T cells. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:E2046-E2053.
25. + T cells. J. Immunol. 2009, 182:4865-4873.
26. + T cell or antibody responses but contribute to protection after vaccination. J. Immunol. 2010, 185:5405-5416.